AKT inhibitors (Consensus)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAKT inhibitors (Consensus)
Drug Alias Nameprotein kinase B inhibitors (Consensus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene proteins c-akt inhibitors
TargetsProto-oncogene proteins c-akt
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConsensus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConsensus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A